Careers & Culture

April 16, 2024 Alnylam Ranked #3 on LinkedIn's List of Top Midsize Companies for 2024 Alnylam is proud to be included on LinkedIn's Top Companies list for 2024. Read More ›
November 30, 2023 Alnylam Named #1 Largest Employer in MA for 3rd Year in a Row by The Boston Globe Alnylam has been named the #1 Largest Employer in MA for the 3rd year in a row and a Top Place to Work for the 9th year in a row. Read More ›
October 26, 2023 Alnylam Named a Top Science Employer by Science Magazine for the 5th Year in a Row Alnylam has been named a Science Magazine Top Employer for the 5th year in a row. Read More ›
July 24, 2023 Alnylam Named a Best Workplace for Millennials for 2023 by Fortune and Great Place to Work Alnylam is ranked #19 on Fortune and Great Place to Work's 2023 list of Best Workplaces for Millennials. Read More ›
July 11, 2023 Alnylam Named a Best Workplace for Innovators for the 3rd Year in a Row by Fast Company Alnylam has been named a Fast Company Best Workplace for Innovators for 2023, our 3rd year in a row. Read More ›
January 31, 2023 Alnylam Named to Bloomberg's Gender-Equality Index for 3rd Year in a Row Alnylam has been named to Bloomberg's Gender Equality Index (GEI) for the 3rd year in a row. Read More ›
November 30, 2022 Alnylam Named #1 Largest Employer in MA for 2nd Year in a Row by The Boston Globe Alnylam is a Boston Globe Top Place to Work for the 8th consecutive year and the #1 ranked company on the "Largest Employers" list for the second year in a row Read More ›
October 26, 2022 Alnylam Named #2 <em>Science Magazine</em> Top Biopharma Employer Alnylam has been named the #2 Science Magazine Top Biopharma Employer for 2022, which marks our 4th year on the list. Read More ›
September 27, 2022 Alnylam Named a Best Workplace for Women by Fortune Magazine Alnylam has been named a Fortune Best Workplace for Women for 2022 Read More ›
August 2, 2022 Alnylam Named #1 Best Workplace for Innovators by Fast Company Alnylam has been named the #1 Best Workplace for Innovators by Fast Company for 2022. Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site